(Q33777239)

29 July 2017

1 reference

title

Overview of trends in the control of cardiac arrhythmia: past and future (English)

1 reference

29 July 2017

Singh BN

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

84

1 reference

29 July 2017

issue

9A

1 reference

29 July 2017

page(s)

3R-10R

1 reference

Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Expanding indications for the use of Class III agents in patients at high risk for sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Rise and Fall of Guided Antiarrhythmic Therapy for Ventricular Tachycardia and Fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Therapy of Sustained Ventricular Arrhythmias With Amiodarone: Prediction of Efficacy With Serial Electrophysiologic Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

An overview of arrhythmias and antiarrhythmic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Importance of beta blockade in the therapy of serious ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Beta-adrenergic blocker mortality trials in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Frequency-dependent electrophysiologic effects of amiodarone in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Cellular electropharmacology of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Amiodarone decreases Na,K-ATPase alpha 2 and beta 2 expression specifically in cardiac ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

What should we expect from the next generation of antiarrhythmic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900696-7

10.1016/S0002-9149(99)00696-7

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference